On August 16, Regeneron Pharmaceuticals, Inc. (REGN) and Teva Pharmaceutical Industries Ltd. (TEVA) announced positive topline results from a Phase 3 clinical trial of Fasinumbab in patients with chronic pain from osteoarthritis of the knee or hip. After 16 weeks, the study met both co-primary endpoints as well as all key secondary endpoints. Patients treated […]
On August 8, Strongbridge Biopharma plc (SBBP) announced top-line results from its Phase 3 SONICS study evaluating RECORLEVTM(levoketoconazole) for the treatment of endogenous Cushing’s syndrome. The open-label, single-arm SONICS study produced statistically significant results of its pre-specified primary endpoint. At six months, 30% of patients demonstrated a normalization rate of Urinary Free Cortisol. Sonal alerted […]
Horizon Pharma plc (HZNP) reported its second-quarter 2018 earnings on August 8. Net sales increased by 4.6% due to strong growth for its orphan and rheumatology medicines. The company increased its annual adjusted EBITDA guidance to between $400 million and $420 million. Horizon Pharma has realigned its operating structure into two segments so that it […]
Fortune Brands Home & Security, Inc. (FBHS) announced its second-quarter 2018 earnings on July 26. Sales increased 5% year-over-year to $1.4 billion. The company increased its guidance for annual EPS before charges/gains to between $3.62 and $3.72. Sonal issued an alert to subscribers at 4:05 pm. The next trade was for $53.97 at 4:06 […]
On July 25, Leidos (LDOS) announced that the company has been awarded a Department of Energy contract to support research for the National Energy Technology Laboratory (NETL). The contract has a three-year base performance period followed by two optional contract periods. It has the potential to extend 10 years for a total valuation of $364.7 […]
On July 24, Ituran Location and Control Ltd. (ITRN) announced that they company acquired a majority of the shares of Road Track Holdings S.L., a telematics company with most of its business in Latin America. Ituran is paying $91.7 million for 81.3% of the company. Ituran is a technology company that provides a full suite […]
Check Point Software Technologies Ltd. (CHKP) announced on July 25 that the company’s Board of Directors authorized a major expansion of the current share repurchase program. The updated repurchase plan is effective immediately and increases the quarterly repurchase 30% to $325 million in outstanding shares. The overall repurchase plan increased 100% to a total of […]
On July 17, Fidelity National Financial, Inc. (FNF) announced that the company’s Board of Directors approved a new stock repurchase program. The new repurchase program replaces the previous stock repurchase program, which expires on July 31. The company repurchased a total of 10.6 million shares of stock with the previous program. The new stock repurchase […]
On July 23, Reata Pharmaceuticals, Inc. (RETA) announced results from two Phase 2 clinical trials of bardoxolone in patients with chronic kidney disease. The one-year results for the Phase 2 portion of CARDINAL, a study of bardoxolone in patients with chronic kidney disease due to Alport syndrome, found that patients had no drug-related negative side […]
Capstone Turbine Corporation (CPST) announced on July 11 that the company has secured nine separate Factory Protection Plan (FPP) aftermarket long-term service contract renewals from a major U.S. oil and gas producer. The contracts cover a total of 4.4 MWs. Capstone Turbine is the world’s leading clean technology manufacturer of microturbine energy systems. Sonal […]
On July 10, Harris Corporation (HRS) reported that the company has been awarded three multi-award IDIQ contracts by the National Geospatial-Intelligence Agency (NGA). Harris will create, manage, and distribute high-quality geospatial intelligence for the US intelligence community and military. The contract covers services for up to 10 years and totals $1.5 billion. Sonal sent […]
Let us send you a summary of the signals Sonal generates EVERY WEEK… and you can decide if you’re missing anything.